{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:10:45Z","timestamp":1786133445823,"version":"build-2736575974"},"reference-count":81,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1681\/asn.2011030221","type":"journal-article","created":{"date-parts":[[2011,9,9]],"date-time":"2011-09-09T22:51:19Z","timestamp":1315608679000},"page":"1785-1794","source":"Crossref","is-referenced-by-count":75,"title":["Current Therapy for IgA Nephropathy"],"prefix":"10.1681","volume":"22","author":[{"given":"J\u00fcrgen","family":"Floege","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Eitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20230423","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/ndt\/4.11.943","article-title":"Frequency of mesangial IgA deposits in a non-selected autopsy series","volume":"4","author":"Waldherr","year":"1989","journal-title":"Nephrol Dial Transplant"},{"key":"R2-5-20230423","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1046\/j.1523-1755.63.6s.2.x","article-title":"Incidence of latent mesangial IgA deposition in renal allograft donors in Japan","volume":"63","author":"Suzuki","year":"2003","journal-title":"Kidney Int"},{"key":"R3-5-20230423","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0002-9343(01)00659-3","article-title":"The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria","volume":"110","author":"Szeto","year":"2001","journal-title":"Am J Med"},{"key":"R4-5-20230423","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1053\/ajkd.1998.v31.pm9631840","article-title":"Chronicity index and mesangial IgG deposition are risk factors for hypertension and renal failure in early IgA nephropathy","volume":"31","author":"Nieuwhof","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"R5-5-20230423","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/ndt\/gfq387","article-title":"Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination\/prednisolone therapy","volume":"26","author":"Shima","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R6-5-20230423","first-page":"160","article-title":"Repeat renal biopsy in children with IgA nephropathy","volume":"33","author":"Yoshikawa","year":"1990","journal-title":"Clin Nephrol"},{"key":"R7-5-20230423","first-page":"2208","article-title":"Disappearance of mesangial IgA deposits from the kidneys of two donors after transplantation","volume":"19","author":"Cuevas","year":"1987","journal-title":"Transplant Proc"},{"key":"R8-5-20230423","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.semnephrol.2004.01.008","article-title":"Recurrent IgA nephropathy after renal transplantation","volume":"24","author":"Floege","year":"2004","journal-title":"Semin Nephrol"},{"key":"R9-5-20230423","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1681\/ASN.2007050526","article-title":"Remission of proteinuria improves prognosis in IgA nephropathy","volume":"18","author":"Reich","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R10-5-20230423","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.semnephrol.2004.01.001","article-title":"Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome","volume":"24","author":"D'Amico","year":"2004","journal-title":"Semin Nephrol"},{"key":"R12-5-20230423","first-page":"503","article-title":"Factors predicting progression of IgA nephropathies","volume":"18","author":"Coppo","year":"2005","journal-title":"J Nephrol"},{"key":"R13-5-20230423","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0272-6386(01)80120-7","article-title":"Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis","volume":"37","author":"Bonnet","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"R14-5-20230423","first-page":"90","article-title":"Clinicopathological influence of obesity in IgA nephropathy: Comparative study of 74 patients","volume":"157","author":"Tanaka","year":"2007","journal-title":"Contrib Nephrol"},{"key":"R15-5-20230423","doi-asserted-by":"crossref","first-page":"c71","DOI":"10.1159\/000213084","article-title":"Impact of obesity on IgA nephropathy: Comparative ultrastructural study between obese and non-obese patients","volume":"112","author":"Tanaka","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"R16-5-20230423","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2215\/CJN.02250409","article-title":"Weight loss interventions in chronic kidney disease: A systematic review and meta-analysis","volume":"4","author":"Navaneethan","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R17-5-20230423","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ki.2009.243","article-title":"The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification","volume":"76","author":"Cattran","year":"2009","journal-title":"Kidney Int"},{"key":"R18-5-20230423","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ki.2009.168","article-title":"The Oxford classification of IgA nephropathy: Pathology definitions, correlations, and reproducibility","volume":"76","author":"Roberts","year":"2009","journal-title":"Kidney Int"},{"key":"R19-5-20230423","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1097\/01.ASN.0000100145.27188.33","article-title":"Management of glomerular proteinuria: A commentary","volume":"14","author":"Wilmer","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R21-5-20230423","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1056\/NEJMcp0906797","article-title":"Clinical practice. Stage IV chronic kidney disease","volume":"362","author":"Abboud","year":"2010","journal-title":"N Engl J Med"},{"key":"R22-5-20230423","first-page":"284","article-title":"Supportive versus immunosuppressive therapy of progressive IgA nephropathy (STOP) IgAN trial: Rationale and study protocol","volume":"21","author":"Eitner","year":"2008","journal-title":"J Nephrol"},{"key":"R23-5-20230423","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1681\/ASN.V8111739","article-title":"Fish oil therapy for IgA nephropathy: Efficacy and interstudy variability","volume":"8","author":"Dillon","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"R24-5-20230423","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1681\/ASN.V1081772","article-title":"The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group","volume":"10","author":"Donadio","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R25-5-20230423","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ndt\/gfn454","article-title":"Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: A randomized controlled trial","volume":"24","author":"Ferraro","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R26-5-20230423","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2215\/CJN.01020905","article-title":"Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: Report from the Southwest Pediatric Nephrology Study Group","volume":"1","author":"Hogg","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R27-5-20230423","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1440-1797.1997.tb00201.x","article-title":"Three year randomized controlled trial of dipyridamole and low-dose warfarin in patients with IgA nephropathy and renal impairment","volume":"3","author":"Lee","year":"1997","journal-title":"Nephrology (Carlton"},{"key":"R28-5-20230423","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1046\/j.1523-1755.2003.00935.x","article-title":"The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy","volume":"63","author":"Xie","year":"2003","journal-title":"Kidney Int"},{"key":"R29-5-20230423","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/ajkd.2001.27690","article-title":"Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy","volume":"38","author":"Hotta","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"R30-5-20230423","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/TP.0b013e3181b75374","article-title":"Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation","volume":"88","author":"Kennoki","year":"2009","journal-title":"Transplantation"},{"key":"R31-5-20230423","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2215\/CJN.00310108","article-title":"Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: A controlled study","volume":"3","author":"Komatsu","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R32-5-20230423","first-page":"147","article-title":"Tonsillectomy does not prevent a progressive course in IgA nephropathy","volume":"51","author":"Rasche","year":"1999","journal-title":"Clin Nephrol"},{"key":"R33-5-20230423","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/ndt\/gfq107","article-title":"Influence of tonsillectomy on the progression of mesangioproliferative glomerulonephritis","volume":"25","author":"Piccoli","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R34-5-20230423","doi-asserted-by":"crossref","first-page":"c86","DOI":"10.1159\/000213086","article-title":"Alcohol consumption and kidney function in IgA glomerulonephritis","volume":"112","author":"Kaartinen","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"R35-5-20230423","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.ajkd.2008.07.029","article-title":"Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: A randomized controlled trial","volume":"53","author":"Lv","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R36-5-20230423","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1093\/ndt\/gfp356","article-title":"Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy","volume":"24","author":"Manno","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R37-5-20230423","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(98)03563-6","article-title":"Corticosteroids in IgA nephropathy: A randomised controlled trial","volume":"353","author":"Pozzi","year":"1999","journal-title":"Lancet"},{"key":"R38-5-20230423","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.ASN.0000103869.08096.4F","article-title":"Corticosteroid effectiveness in IgA nephropathy: Long-term results of a randomized, controlled trial","volume":"15","author":"Pozzi","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R39-5-20230423","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0272-6386(03)00194-X","article-title":"Controlled, prospective trial of steroid treatment in IgA nephropathy: A limitation of low-dose prednisolone therapy","volume":"41","author":"Katafuchi","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R40-5-20230423","first-page":"1559","article-title":"High incidence of osteonecrosis of femoral head in patients receiving more than 2 g of intravenous methylprednisolone after renal transplantation","volume":"28","author":"Saisu","year":"1996","journal-title":"Transplant Proc"},{"key":"R42-5-20230423","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/01.ASN.0000068460.37369.DC","article-title":"Treatment of IgA nephropathy with ACE inhibitors: A randomized and controlled trial","volume":"14","author":"Praga","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R43-5-20230423","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1681\/ASN.2006040347","article-title":"IgACE: A placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria","volume":"18","author":"Coppo","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R44-5-20230423","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1093\/ndt\/gfn394","article-title":"The improvement of renal survival with steroid pulse therapy in IgA nephropathy","volume":"23","author":"Katafuchi","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R46-5-20230423","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1681\/ASN.2010010117","article-title":"Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy","volume":"21","author":"Pozzi","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R47-5-20230423","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1523-1755.2005.00460.x","article-title":"Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy","volume":"68","author":"Tang","year":"2005","journal-title":"Kidney Int"},{"key":"R49-5-20230423","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1523-1755.2004.00588.x","article-title":"Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study","volume":"65","author":"Maes","year":"2004","journal-title":"Kidney Int"},{"key":"R50-5-20230423","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/ndt\/gfh974","article-title":"Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: A double-blind randomized controlled trial","volume":"20","author":"Frisch","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R51-5-20230423","first-page":"136","article-title":"One-year angiotensin-converting enzyme inhibition plus mycophenolate mofetil immunosuppression in the course of early IgA nephropathy: A multicenter, randomised, controlled study","volume":"18","author":"Dal Canton","year":"2005","journal-title":"J Nephrol"},{"key":"R52-5-20230423","first-page":"796","article-title":"[A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy]","volume":"82","author":"Chen","year":"2002","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"R53-5-20230423","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/ncpneph0067","article-title":"Is mycophenolate mofetil an effective treatment for persistent proteinuria in patients with IgA nephropathy?","volume":"2","author":"Floege","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"R54-5-20230423","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1093\/ndt\/gfn161","article-title":"Delayed severe pneumonia in mycophenolate mofetil-treated patients with IgA nephropathy","volume":"23","author":"Lv","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R55-5-20230423","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00467-007-0731-8","article-title":"Combination therapy with mizoribine for severe childhood IgA nephropathy: A pilot study","volume":"23","author":"Yoshikawa","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R56-5-20230423","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/ndt\/12.10.2206","article-title":"Long-term treatment of IgA nephropathy with cyclosporin A\u2013a preliminary report","volume":"12","author":"Chabova","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"R57-5-20230423","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.295.6607.1165","article-title":"Cyclosporin treatment of IgA nephropathy: A short term controlled trial","volume":"295","author":"Lai","year":"1987","journal-title":"BMJ (Clin Res Ed"},{"key":"R58-5-20230423","doi-asserted-by":"crossref","first-page":"c137","DOI":"10.1159\/000070233","article-title":"Cohort study of advanced IgA nephropathy: Efficacy and limitations of corticosteroids with tonsillectomy","volume":"93","author":"Sato","year":"2003","journal-title":"Nephron Clin Pract"},{"key":"R59-5-20230423","doi-asserted-by":"crossref","first-page":"C58","DOI":"10.1159\/000068522","article-title":"Prednisolone and azathioprine in IgA nephropathy - a ten-year follow-up study","volume":"93","author":"Goumenos","year":"2003","journal-title":"Nephron Clin Pract"},{"key":"R60-5-20230423","first-page":"263","article-title":"Effect of corticosteroid and cyclophosphamide in IgA nephropathy patients with heavy proteinuria and\/or moderate-severe pathological changes","volume":"66","author":"Chen","year":"2003","journal-title":"J Chin Med Assoc"},{"key":"R61-5-20230423","first-page":"165","article-title":"Long-term effects of intensive therapy combined with tonsillectomy in patients with IgA nephropathy","volume":"523","author":"Hotta","year":"1996","journal-title":"Acta Otolaryngol Suppl"},{"key":"R62-5-20230423","first-page":"1","article-title":"Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy","volume":"53","author":"Tsuruya","year":"2000","journal-title":"Clin Nephrol"},{"key":"R63-5-20230423","first-page":"60","article-title":"Effects of triple therapy in IgA nephritis: A follow-up study 5 years later","volume":"36","author":"Woo","year":"1991","journal-title":"Clin Nephrol"},{"key":"R64-5-20230423","first-page":"103","article-title":"The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: A two-year prospective trial","volume":"34","author":"Walker","year":"1990","journal-title":"Clin Nephrol"},{"key":"R65-5-20230423","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1681\/ASN.V101101","article-title":"A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group","volume":"10","author":"Yoshikawa","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R66-5-20230423","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2215\/CJN.01120905","article-title":"Steroid treatment for severe childhood IgA nephropathy: A randomized, controlled trial","volume":"1","author":"Yoshikawa","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R67-5-20230423","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1681\/ASN.V131142","article-title":"Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy","volume":"13","author":"Ballardie","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R68-5-20230423","first-page":"465","article-title":"Mycophenolic acid therapy after cyclophosphamide pulses in progressive IgA nephropathy","volume":"19","author":"Rasche","year":"2006","journal-title":"J Nephrol"},{"key":"R69-5-20230423","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000422389","article-title":"Typical and atypical natural history of IgA nephropathy in adult patients","volume":"104","author":"D'Amico","year":"1993","journal-title":"Contrib Nephrol"},{"key":"R70-5-20230423","first-page":"285","article-title":"The \u201cpoint of no return\u201d and the rate of progression in the natural history of IgA nephritis","volume":"52","author":"Scholl","year":"1999","journal-title":"Clin Nephrol"},{"key":"R71-5-20230423","first-page":"690","article-title":"\u201cPoint of no return (PNR)\u201d in progressive IgA nephropathy: Significance of blood pressure and proteinuria management up to PNR","volume":"18","author":"Komatsu","year":"2005","journal-title":"J Nephrol"},{"key":"R72-5-20230423","first-page":"175","article-title":"Patients with IgA nephropathy whose renal function remains stable for a long time even after exceeding the \u201cpoint of no return\u201d","volume":"54","author":"Ota","year":"2000","journal-title":"Clin Nephrol"},{"key":"R73-5-20230423","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1056\/NEJMoa053107","article-title":"Efficacy and safety of benazepril for advanced chronic renal insufficiency","volume":"354","author":"Hou","year":"2006","journal-title":"N Engl J Med"},{"key":"R74-5-20230423","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1523-1755.2004.00833.x","article-title":"Clinicopathologic correlations of renal pathology in Spain","volume":"66","author":"Rivera","year":"2004","journal-title":"Kidney Int"},{"key":"R75-5-20230423","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2215\/CJN.02670706","article-title":"Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy","volume":"2","author":"Gutierrez","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R76-5-20230423","first-page":"360","article-title":"Treatment of vasculitic IgA nephropathy","volume":"13","author":"Harper","year":"2000","journal-title":"J Nephrol"},{"key":"R77-5-20230423","first-page":"2054","article-title":"Report on intensive treatment of extracapillary glomerulonephritis with focus on crescentic IgA nephropathy","volume":"10","author":"Roccatello","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"R78-5-20230423","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ndt\/gfg081","article-title":"Crescentic, proliferative IgA nephropathy: Clinical and histological response to methylprednisolone and intravenous cyclophosphamide","volume":"18","author":"Tumlin","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R79-5-20230423","doi-asserted-by":"crossref","first-page":"c16","DOI":"10.1159\/000210570","article-title":"Vasculitic IgA nephropathy: Prognosis and outcome","volume":"112","author":"Pankhurst","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"R80-5-20230423","first-page":"174","article-title":"Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: A long-term controlled trial","volume":"26","author":"Lai","year":"1986","journal-title":"Clin Nephrol"},{"key":"R81-5-20230423","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1681\/ASN.2010060611","article-title":"Postinfectious glomerulonephritis in the elderly","volume":"22","author":"Nasr","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R82-5-20230423","first-page":"333","article-title":"Glomerulonephritis associated with liver cirrhosis","volume":"33","author":"Endo","year":"1983","journal-title":"Acta Pathol Jpn"},{"key":"R83-5-20230423","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/BOR.0b013e32833af608","article-title":"Henoch-Schonlein purpura","volume":"22","author":"Saulsbury","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"R85-5-20230423","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s00467-008-1066-9","article-title":"Treatment-based literature of Henoch-Schonlein purpura nephritis in childhood","volume":"24","author":"Zaffanello","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"R86-5-20230423","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/ndt\/gfh773","article-title":"Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil","volume":"20","author":"Chandrakantan","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R87-5-20230423","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1093\/ndt\/gfl506","article-title":"Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?","volume":"21","author":"Courtney","year":"2006","journal-title":"Nephrol Dial Transplant"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201110000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:34:05Z","timestamp":1786131245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201110000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":81,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2011030221","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}